RT Journal Article
SR Electronic
T1 Candesartan and Amlodipine: Effect on the Incidence of Cardiovascular Events and New-Onset Diabetes
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 5
SP 12
OP 12
DO 10.1177/155989771005010
UL http://mdc.sagepub.com/content/10/5/12.1.abstract
AB The 3-year extension of the Candesartan Antihypertensive Survival Evaluation in Japan [CASE-J] Study demonstrated comparable efficacy of the angiotensin receptor blocker candesartan and the calcium channel blocker amlodipine on the incidence of cardiovascular events in high-risk hypertensive Japanese patients. As observed in the earlier phase of the study, cadesartan exhibited sustained superiority over amlodipine with regards to reduction in new-onset diabetes throughout the 3-year extended follow up.